As a Contract Research Organization, it is important for Veristat to constantly grow and change as the industry grows and changes. This is why Veristat began offering clinical monitoring as a core service; to expand its already solid service foundation in clinical trials and provide the most to our clients. Three years ago Veristat established a clinical monitoring department rather than continuing with the established partnerships we had used in the decade prior. In this time we have assisted in running several Phase III trials and look forward to the growth that lies ahead.
Veristat’s clinical monitoring department manages the complete monitoring process with each client from initial site selection, site qualification and feasibility surveys through all site initiation visits and into the final close-out of each site. Veristat works closely with the site staff and investigator to ensure total compliance with United States Food and Drug Administration (FDA) regulations, International Conference on Harmonisation (ICH) and Good Clinical Practice (GCP) guidelines, the approved clinical study protocol and clinical monitoring plan, and applicable Standard Operating Procedures (SOPs).
Veristat’s clinical monitoring personnel promote the development and maintenance of positive, professional working relationships with investigative site personnel. Focused telephone contact between scheduled on-site visits fosters these relationships and ensures optimal use of study personnel time during scheduled on-site visits. Internally, clinical monitoring, data management, and biostatistical personnel work in a coordinated fashion to ensure maximum efficiency of on-site monitoring visits as well as data availability for project milestones and analyses.
For more information on Veristat and how our clinical monitoring department can assist you please email Cindy Henderson at info@veristat.com
As a Contract Research Organization, it is important for Veristat to constantly grow and change as the industry grows and changes. This is why Veristat began offering clinical monitoring as a core service; to expand its already solid service foundation in clinical trials and provide the most to our clients. Three years ago Veristat established a clinical monitoring department rather than continuing with the established partnerships we had used in the decade prior. In this time we have assisted in running several Phase III trials and look forward to the growth that lies ahead.
Veristat’s clinical monitoring department manages the complete monitoring process with each client from initial site selection, site qualification and feasibility surveys through all site initiation visits and into the final close-out of each site. Veristat works closely with the site staff and investigator to ensure total compliance with United States Food and Drug Administration (FDA) regulations, International Conference on Harmonisation (ICH) and Good Clinical Practice (GCP) guidelines, the approved clinical study protocol and clinical monitoring plan, and applicable Standard Operating Procedures (SOPs).
Veristat’s clinical monitoring personnel promote the development and maintenance of positive, professional working relationships with investigative site personnel. Focused telephone contact between scheduled on-site visits fosters these relationships and ensures optimal use of study personnel time during scheduled on-site visits. Internally, clinical monitoring, data management, and biostatistical personnel work in a coordinated fashion to ensure maximum efficiency of on-site monitoring visits as well as data availability for project milestones and analyses.
For more information on Veristat and how our clinical monitoring department can assist you please email Cindy Henderson at info@veristat.com